DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A••••••• H•••••••• I••
Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Nothing material in the last 200 days. No dated change on record yet.
Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
$22,000
n/a on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
3
3 on the latest quarter
Facilities
0
2 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Sep 30, 2023
latest Mar 31, 2026
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Mar 31, 2026, folded to one row per lender
Every BDC piece · 3 positions across 3 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| S•• P•••••• C••••• I••••• B•• L•• | equity equity C••••• Equity C••••• S•••• I••••••• P••••••••• A••••••••• D••• 7/2023 | Not disclosed | $5,000 29c | |
| S•• H• B•• L•• | warrants equity C••••• S•••• | C••••• Equity/W••••••• | 7/2023 | Not disclosed | $1,000 25c | |
| S•• I••••••••• C•••• | warrants equity C••••• Equity/Equity I••••••••/W••••••• | 7/2023 | Not disclosed | $16,000 31c |
Capital structure as the BDCs see it
latest quarter end Mar 31, 2026
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2026 | 3 | $0 | $0 | n/a | 0 |
| Dec 31, 2025 | 3 | $0 | $0 | n/a | 0 |
| Sep 30, 2025 | 3 | $0 | $0 | n/a | 0 |
| Jun 30, 2025 | 3 | $0 | $0 | n/a | 0 |
All 11 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2025 | 3 | $0 | $0 | n/a | 0 |
| Dec 31, 2024 | 3 | $0 | $0 | n/a | 0 |
| Sep 30, 2024 | 3 | $0 | $0 | n/a | 0 |
| Jun 30, 2024 | 3 | $0 | $0 | n/a | 0 |
| Mar 31, 2024 | 3 | $0 | $0 | n/a | 0 |
| Dec 31, 2023 | 3 | $0 | $0 | n/a | 0 |
| Sep 30, 2023 | 3 | $0 | $0 | n/a | 0 |
What changed
- New borrower on a BDC scheduleSep 30, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- ASSERTIOderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 3 BDCsderived
- Industry
- Pharmaceuticalsreportedas one filer wrote it